| PACKAGING TYPE: | Blister (10 Strips In 1 Box) |
| COMPOSITION: | Each Uncoated Bilayered Tablet Contains - Sitagliptin Phosphate Monohydrate Ip Eq To Sitagliptin 100mg , Metformin Hydrochloride Ip (in Extended Release Form) 1000 Mg |
| FORMULATION: | Tablet |
| Description: | S.P. 100/1000 MG Tablet is a combination anti-diabetic medicine formulated with Sitagliptin and Extended-Release Metformin (ER). It is used for the effective management of type 2 diabetes mellitus in adults. Sitagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels, while Metformin ER ensures prolonged glucose control by decreasing hepatic glucose production and improving insulin sensitivity. The extended-release formulation provides sustained action with improved gastrointestinal tolerability and convenient once-daily dosing. |
| Side Effects: | Common side effects may include: Nausea Diarrhea Stomach upset Headache Flatulence Serious (rare) side effects: Lactic acidosis (due to Metformin) Pancreatitis (due to Sitagliptin) Severe hypersensitivity reactions |
| How to Use: | Take the tablet as prescribed by your doctor Usually taken once daily with the evening meal or as directed Swallow whole with water; do not crush, break, or chew Follow recommended diet and exercise routine Do not skip doses for consistent blood sugar control |
| Precaution: | Not recommended in severe kidney or liver impairment Avoid excessive alcohol intake Monitor kidney function regularly Use cautiously in elderly patients Inform doctor if you have a history of pancreatitis Consult before use during pregnancy or breastfeeding Do not crush ER tablets as it may affect drug release |
| Product Benefits: | Provides strong and sustained blood sugar control Extended-release Metformin ensures prolonged action Improves insulin secretion and sensitivity Reduces glucose production in the liver Lower chances of gastrointestinal discomfort compared to immediate |
Frequently Asked Questions
It is used to control high blood sugar levels in patients with type 2 diabetes mellitus.
Extended-release Metformin provides sustained glucose control with fewer gastrointestinal side effects and convenient dosing.
Yes, it contains a higher dose of Sitagliptin (100mg), offering enhanced glycemic control.

















